Transfusion-associated infections: 50 years of relentless challenges and remarkable progress.
about
Chagas disease: "the new HIV/AIDS of the Americas"Transfusion-Transmitted InfectionsPerioperative blood management strategies for patients undergoing total knee replacement: Where do we stand now?Performance evaluation of the Elecsys syphilis assay for the detection of total antibodies to Treponema pallidumDemographic determinants of syphilis seroprevalence among U.S. blood donors, 2011-2012.Occult hepatitis B virus infection and blood transfusionFirst Documented Transmission of Trypanosoma cruzi Infection through Blood Transfusion in a Child with Sickle-Cell Disease in Belgium.Alternative blood products and clinical needs in transfusion medicineDeterminants of peri-operative blood transfusion in a contemporary series of open prostatectomy for benign prostate hyperplasiaSurveillance of Chagas disease among at-risk blood donors in Italy: preliminary results from Umberto I Polyclinic in RomeThe effectiveness and safety of preoperative use of erythropoietin in patients scheduled for total hip or knee arthroplasty: A systematic review and meta-analysis of randomized controlled trials.Demographic, risk factors and motivations among blood donors with reactive serologic tests for syphilis in São Paulo, BrazilMeasuring the impact of ambulatory red blood cell transfusion on home functional status: study protocol for a pilot randomized controlled trial.From bloodless surgery to patient blood management.A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States.Improved blood utilization using real-time clinical decision support.Safety of platelet transfusion: past, present and future.Syphilis transmission: a review of the current evidence.Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial.How do we utilize a transfusion safety officer?Evaluating appropriate red blood cell transfusions: a quality audit at 10 Ontario hospitals to determine the optimal measure for assessing appropriateness.The contribution of unsafe blood transfusion to human immunodeficiency virus incidence in sub-Saharan Africa: reexamination of the 5% to 10% convention.Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literature.Modeling complete removal of risk assessment questions in the USA predicts the risk of HIV exposure in blood recipients could increase despite the use of nucleic acid testing.Contrasting HCV and HIV seroepidemiology in 11 years of blood donors screening in Brazil.Blood system changes since recognition of transfusion-associated AIDS.Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.Transmission of human immunodeficiency virus Type-1 by fresh-frozen plasma treated with methylene blue and light.Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc TestingModeling the transmission risk of emerging infectious diseases through blood transfusion.Local Administration of Tranexamic Acid During Prostatectomy Surgery: Effects on Reducing the Amount of BleedingTransfusion-transmitted syphilis in teaching hospital, Ghana.Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates.Assuring blood safety and availability: Zika virus, the latest emerging infectious disease battlefront.Patients' and health care professionals' perceptions of blood transfusion: a systematic review.Seroepidemiological Study of Hepatitis B, C and HIV among Blood Donors in KermanTherapeutic efficacy of platelet components treated with amotosalen and ultraviolet A pathogen inactivation method: results of a meta-analysis of randomized controlled trials.Hospital-based transfusion error tracking from 2005 to 2010: identifying the key errors threatening patient transfusion safety.Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial.Processing of small volumes in blood salvage devices.
P2860
Q21144502-F54CEAFE-4BE1-4817-98EE-5BBBEA1469C6Q29571219-B3CAE985-51B1-4C6D-A642-F1306F0A6ADAQ33818396-077D3459-AFB6-4334-8803-49396CEA81EAQ34784995-2645B59F-527B-46BE-81A3-39A37D76EAC4Q35205106-0C1DE41D-7DFC-44A8-8970-670260B7B0EAQ35237335-A7FC0743-23A0-44CE-8B6A-996B6E016FA3Q35808368-17DAC679-FFAB-4334-B209-60FEC133BD0CQ35915095-81FA2C74-7C67-48C3-BF5F-1F6E2CF62F1CQ35971951-1E16FF34-DE78-4A03-A9EE-4420B7C06BC4Q37306778-2B266B43-25D2-44CE-8440-39F4A9495533Q37328116-2A53477F-52AC-4DAD-BBAC-B217B54991E7Q37333847-A30C495E-B8B3-45C4-A9F1-9BB8A7E3B45BQ37731581-6B0C34F8-4D8C-4B32-B486-92EAE829B191Q37975177-0565BEB5-A26E-4FC9-93DC-1293B05F9C00Q38052141-C2830599-87D9-49FF-95FF-FF1FD9F1959EQ38151791-CAB51ED9-5D1E-4FCE-BCC0-BA421054A0D5Q38197714-12F4B623-BE4A-4468-B208-54ABC2E0DBAFQ38363529-D3B69797-3F2D-44FD-BB01-6FF13625573BQ38482466-C5504305-6D2D-48D3-90E3-F6672463FFC9Q38512109-5BC89385-1E85-4C6B-9500-717DE5B28CA1Q38910522-AE273B0F-2C7E-4C6F-AFF9-EFE1EB31616CQ38963030-2B6EE538-0D37-4E63-9B74-4D820675F7EDQ38985177-84A444A3-0159-40B2-ACEB-DF540423EF12Q40109325-432EE909-F2FC-4449-A022-17676EAAB019Q40194957-B90A0BE9-A3C7-49CF-B29C-DAEA95D8F625Q40234714-21EA8F1B-F10C-4963-82C9-17784E0529A1Q40818421-C202C2FF-9FAA-4129-9932-23E66B8D0668Q40903377-087FD01A-89FB-4270-B25E-8A071B1CAB5AQ41111337-20131297-E7C7-461D-9A21-CD835C4CB4B2Q42288202-C516CC07-6F66-4A80-8E5D-249AAB562F5AQ42364432-677FE6F0-1CAB-4890-A34E-59AB671B870BQ42572413-CA8BDD7A-EF59-4A50-A0C7-5F91D8D4FE14Q42792674-E31CD5C5-F0C1-4CEA-A1F2-968BFB4D1A28Q42994670-ED631F99-2D3D-49E6-B4DE-41DEEA5CF415Q47278359-45C30FE2-6861-4645-AD21-5E20301192FAQ47559783-53213B55-6A4F-4B01-8085-BA24DCB958A4Q47799625-ED0A70D5-4487-4A26-85D8-286F7EEF6E72Q48723396-7D1C625B-68F2-4251-AD35-8FB148D92C46Q50215380-B0D68C84-90C5-4935-8A10-B26CDF2415D5Q50468092-F1FC09D8-1E35-4BB4-9286-93539AC12A8A
P2860
Transfusion-associated infections: 50 years of relentless challenges and remarkable progress.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Transfusion-associated infecti ...... enges and remarkable progress.
@ast
Transfusion-associated infecti ...... enges and remarkable progress.
@en
Transfusion-associated infecti ...... enges and remarkable progress.
@nl
type
label
Transfusion-associated infecti ...... enges and remarkable progress.
@ast
Transfusion-associated infecti ...... enges and remarkable progress.
@en
Transfusion-associated infecti ...... enges and remarkable progress.
@nl
prefLabel
Transfusion-associated infecti ...... enges and remarkable progress.
@ast
Transfusion-associated infecti ...... enges and remarkable progress.
@en
Transfusion-associated infecti ...... enges and remarkable progress.
@nl
P2860
P1433
P1476
Transfusion-associated infecti ...... enges and remarkable progress.
@en
P2093
Herbert A Perkins
P2860
P304
P356
10.1111/J.1537-2995.2010.02851.X
P577
2010-10-01T00:00:00Z